SKLB-197

N/A

Report date: 2022/04/26 17:27:00
NME

Base Information

Drug NameSKLB-197
Drug Alias NameSKLB-197
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsAtaxia Telangiectasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWest China School Of Pharmcy Sichuan University
China Registration ClassN/A

Develop Information

Active CompaniesWest China School Of Pharmcy Sichuan University
Inactive CompaniesN/A
Active IndicationsAtaxia Telangiectasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A